Amundi Pulmonx Corp Transaction History

Amundi

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.88 - $14.0 $94,067 - $133,294	9,521 Added 55.79%	26,586 $274,000
Q2 2023 Aug 14, 2023	BUY	$10.78 - $13.65 $183,960 - $232,937	17,065 New	17,065 $223,000
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $39,326 - $61,462	2,562 New	2,562 $44,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $35,667 - $60,177	-1,688 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$29.72 - $45.1 $50,167 - $76,128	1,688 New	1,688 $49,000

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.